Search Results - "Degeorges, A."

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy by Bidard, F.-C., Mathiot, C., Degeorges, A., Etienne-Grimaldi, M.-C., Delva, R., Pivot, X., Veyret, C., Bergougnoux, L., de Cremoux, P., Milano, G., Pierga, J.-Y.

“…We investigated whether circulating tumor cells (CTCs) and circulating endothelial cells (CECs) predict clinical outcome of first-line chemotherapy combined…”
Get full text

Measles and rubella seroprevalence in a population of young adult blood donors, France 2013 by Antona, D, Morel, P, Jacquot, C, Fonteneau, L, Dina, J, Vauloup-Fellous, C, Gimeno, L, Degeorges, A, Gallian, P, Lévy-Bruhl, D

“…As part of the evaluation of the French plan for the elimination of measles and rubella, we conducted a seroprevalence survey in 2013, aimed at updating…”
Get full text

Circulating tumor cells and breast cancer: detection techniques and clinical results by Bidard, F-C, Saliba, A-E, Saias, L, Degeorges, A, Cremoux, P de, Viovy, J-L, Vincent-Salomon, A, Mathiot, C, Pierga, J-Y, de Gramont, A

“…Due to recent technological progresses, Circulating Tumor Cells (CTC) are currently extensively studied in order to define their diagnostic, prognostic and…”
Get more information

108 CEC and CTC in stage IV breast cancers treated with bevacizumab (Bv) and chemotherapy (CT) by Bidard, F.C, Mathiot, C, Degeorges, A, Formento, P, Delva, R, Pivot, X, de Cremoux, P, Bobadilla, L, Milano, G, Pierga, J.Y

Get full text

P16 Biological profiles of two ERBB2-amplified human breast cancer xenografts diversely sensitive to Trastuzumab by de Plater, L, Marangoni, E, Assayag, F, Auger, N, Degeorges, A, Guyader, C, Vincent-Salomon, A, de Cremoux, P, Decaudin, D, Poupon, M.-F

Get full text

Cellules tumorales circulantes et cancer du sein : méthodes de détection et résultats cliniques by BIDARD, F.-C, SALIBA, A.-E, SAIAS, L, DEGEORGES, A, DE CREMOUX, P, VIOVY, J.-L, VINCENT-SALOMON, A, MATHIOT, C, PIERGA, J.-Y, DE GRAMONT, A

Get full text

Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3 by BORGET, I, CADRANEL, J, DANIEL, C, MORIN, F, CHOUAID, C, PIGNON, J.-P, QUOIX, E, COUDERT, B, WESTEEL, V, DANSIN, E, MADELAINE, J, MADROSZYK, A, FRIARD, S

“…Several clinical and biological parameters are known to influence the efficacy of second-line erlotinib therapy for nonsmall cell lung cancer (NSCLC), but…”
Get full text

LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis by Thalmann, George N., Sikes, Robert A., Wu, Tony T., Degeorges, Armelle, Chang, Shi-Ming, Ozen, Mustafa, Pathak, Sen, Chung, Leland W.K.

“…BACKGROUND Clinically, the lethal phenotypes of human prostate cancer are characterized by their progression to androgen‐independence and their propensity to…”
Get full text

The somatostatin receptor subtype 2 is expressed in normal and tumoral human tissues70 by Prévost, G, Benamouzig, R, Veber, N, Fajac, A, Tatoud, R, Degeorges, A, Eden, P

“…Somatostatin (SS) can inhibit growth hormone (GH) secretion from the pituitary and tumor cell proliferation via membrane-bound receptors (SST). Five SST…”
Get more information

Circulating Endothelial Cells (CEC) as an Early Surrogate Marker and Circulating Tumor Cells (CTC) as a Prognostic Factor in Metastatic Breast Cancer (MBC) Patients Treated First-Line with Bevacizumab (Bv) and Chemotherapy (CT): A French Sub-Study of the Phase IIIb International Multicentre MO19391 Trial by Bidard, F., Mathiot, C., Degeorges, A., Formento, P., Francoual, M., Coulon-Sfairi, M., Espié, M., De Cremoux, P., Levaché, C., Dalenc, F., Bobadilla, L., Milano, G., Pierga, J.

“…Abstract Background: Detection of circulating tumor cells (CTC) is an independent prognostic factor in MBC. A decrease of CTC during treatment is associated…”
Get full text

In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects by Filleur, S, Volpert, O V, Degeorges, A, Voland, C, Reiher, F, Clézardin, P, Bouck, N, Cabon, F

“…Thrombospondin 1 (TSP1) is a multifunctional protein able to activate TGFbeta and to inhibit angiogenesis in vivo. Although usually thought of as an inhibitor…”
Get full text

Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate by COLOMBEL, Marc, FILLEUR, Stéphanie, CABON, Florence, FOURNIER, Pierick, MERLE, Carole, GUGLIELMI, Julien, COURTIN, Aurélie, DEGEORGES, Armelle, SERRE, Claire Marie, BOUVIER, Raymonde, CLEZARDIN, Philippe

“…In order to understand why the angiogenesis inhibitor thrombospondin-1 (TSP1) is often, although not always, associated with prostatic tumors, we have…”
Get full text

Tumour Aromatase Expression, a Prognostic for Local Control in Young Breast Cancer Patients after Breast-Conserving Treatment? by Bollet, M., Savignoni, A., De Koning, L., Tran Perennou, C., Barbaroux, C., Degeorges, A., Sigal-Zafrani, B., Almouzni, G., Cottu, P., Salmon, R., Servant, N., Fourquet, A., de Cremoux, P.

“…Abstract Introduction: To determine whether the levels of expression of 17 candidate genes were associated with locoregional control after breast conserving…”
Get full text

Eco-Politics of Dams on the Gambia River by Degeorges, Andre, Reilly, B. K.

“…In the 1980s, USAID (US Agency for International Development) funded an environmental assessment of dams on the Gambia River, which determined that…”
Get full text

Dams and large scale irrigation on the Senegal River: impacts on man and the environment by Degeorges, Andre, Reilly, B.K.

“…In the construction of the Diama and Manantali Dams, Senegal, constraints to large scale irrigation were not adequately taken into account, while to date…”
Get full text

Distribution of IGFBP-rP1 in Normal Human Tissues by Degeorges, Armelle, Wang, Fuan, Frierson, Henry F., , Jr, Seth, Arun, Sikes, Robert A

“…IGFBP-rP1/mac25 is a recently described member of the insulin-like growth factor binding protein (IGFBP) family. It has structural homology to the other…”
Get full text

Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co‐culture by Bourhis, Xuefen Dong‐Le, Berthois, Yolande, Millot, Guy, Degeorges, Armelle, Sylvi, Monique, Martin, Pierre‐Marie, Calvo, Fabien

“…Stromal and epithelial components surrounding neoplastic cells are believed to be important in tumor regulation. We have studied the effects of stromal and…”
Get full text

Stromal cells from human benign prostate hyperplasia produce a growth‐inhibitory factor for LNCaP prostate cancer cells, identified as interleukin‐6 by Degeorges, Armelle, Tatoud, Roger, Fauvel‐Lafeve, Françoise, Podgorniak, Marie‐Pierre, Millot, Guy, de Cremoux, Patricia, Calvo, Fabien

“…To understand specific interactions between stromal cells and epithelial cells in benign prostatic hyperplasia (BPH) and prostatic adenocarcinoma, we developed…”
Get full text

The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun by DEJONG, V, DEGEORGES, A, FILLEUR, S, AIT-SI-ALI, S, METTOUCHI, A, BORNSTEIN, P, BINETRUY, B, CABON, F

“…Thrombospondin 1 (TSP1) is known for its significant anti-angiogenic properties. In a previous study, we have shown that transient or stable overexpression of…”
Get full text

Human prostate cancer expresses the low affinity insulin-like growth factor binding protein IGFBP-rP1 by DEGEORGES, A, FUAN WANG, FRIERSON, H. F, SETH, A, CHUNG, L. W. K, SIKES, R. A

“…Many of the alterations in the insulin-like growth factor (IGF) axis in prostatic disease have been associated with changes in the insulin-like growth factor…”
Get full text